Blood pressure levels in pre-diabetic stages are associated with worse cognitive functioning in patients with type 2 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 25, Issue 7, 2009, Pages 657-664

  Van Den Berg, Esther ^a   Dekker, Jacqueline M ^b   Nijpels, Giel ^b   Kessels, Roy P C ^c,d,e   Kappelle, L Jaap ^a   De Haan, Edward H F ^f   Heine, Robert J ^b   Stehouwer, Coen D A ^g   Biessels, Geert Jan ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UTRECHT UNIVERSITY   (Netherlands)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

^g MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Blood pressure; Cognitive functioning; Exposure; Type 2 diabetes mellitus; Vascular risk factors

Indexed keywords

GLUCOSE; LIPID;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIPID BLOOD LEVEL; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; LINEAR MODELS; LIPIDS; MALE; MIDDLE AGED; PREDIABETIC STATE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; WAIST CIRCUMFERENCE;

EID: 70350614142     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1009     Document Type: Article

References (41)

1. Awad N, Gagnon M, Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol 2004; 26: 1044-1080. (Pubitemid 39577337)
2. Strachan MWJ, Deary IJ, Ewing FME, Frier BM. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 1997; 20: 438-445.
3. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006; 5: 64-74. (Pubitemid 41790697)
4. Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K. Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 2004; 164: 1327-1333. (Pubitemid 38828884)
5. van Harten B, Oosterman J, Muslimovic D, van Loon BJ, Scheltens P, Weinstein HC. Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus. Age Ageing 2007; 36: 164-170. (Pubitemid 46455395)
6. Bruce DG, Davis WA, Casey GP, et al. Predictors of cognitive decline in older individuals with diabetes. Diabetes Care 2008; 31: 2103-2107.
7. Hassing LB, Hofer SM, Nilsson SE, et al. Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study. Age Ageing 2004; 33: 355-361. (Pubitemid 39077242)
8. Bruce DG, Davis WA, Casey GP, et al. Predictors of cognitive impairment and dementia in older people with diabetes. Diabetologia 2008; 51: 241-248.
9. van den Berg E, Dekker JM, Nijpels G, et al. Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: the Hoorn study. Dement Geriatr Cogn Disord 2008; 26: 261-269.
10. Vanhanen M, Koivisto K, Kuusisto J, et al. Cognitive function in an elderly population with persistent impaired glucose tolerance. Diabetes Care 1998; 21: 398-402. (Pubitemid 28101075)
11. Lernfelt B, Svanborg A. Change in blood pressure in the age interval 70-90. Late blood pressure peak related to longer survival. Blood Press 2002; 11: 206-212.
12. Newman AB, Yanez D, Harris T, Duxbury A, Enright PL, Fried LP. Weight change in old age and its association with mortality. J Am Geriatr Soc 2001; 49: 1309-1318. (Pubitemid 33015207)
13. Kloppenborg RP, van den Berg E, Kappelle LJ, Biessels GJ. Diabetes and other vascular risk factors for dementia: Which factor matters most? A systematic review. Eur J Pharmacol 2008; 585: 97-108.
14. Mooy JM, Grootenhuis PA, de Vries H, et al, The Hoorn Study. Prevalence and determinants of glucose intolerance in a Dutch caucasian population. Diabetes Care 1995; 18: 1270-1273.
15. World Health Organization. Diabetes Mellitus: Report of a WHO Study Group. Research Report Series No. 727, World Health Organization: Geneva, 1985.
16. World Health Organization. Definition, diagnosis and classification of diabetes mellitus: report of a WHO consultation. Publication WHO/NCD/NCS/99 2, 1999.
17. Adult Treatment Panel III. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
18. Rose G, Blackburn H, Gillum RF. Cardiovascular Survey Methods. WHO Press: Geneva, 1982.
19. Manschot SM, Brands AM, van der Grond J, et al. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 2006; 55: 1106-1113. (Pubitemid 44100188)
20. Schmand B, Lindenboom J, Van Harskamp F. Nederlandse Leestest Voor Volwassenen. Swets & Zeitlinger: Lisse, 1992.
21. Hochstenbach J, Mulder T, Van LJ, Donders R, Schoonderwaldt H. Cognitive decline following stroke: a comprehensive study of cognitive decline following stroke. J Clin Exp Neuropsychol 1998; 20: 503-517. (Pubitemid 29030414)
22. Beekman AT, Deeg DJ, Van LJ, Braam AW, De Vries MZ, Van TW. Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in The Netherlands. Psychol Med 1997; 27: 231-235.
23. Gueorguieva R, Krystal JH. Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry 2004; 61: 310-317. (Pubitemid 38295833)
24. Elias PK, Elias MF, D'Agostino RB, et al, The Framingham Study. NIDDM and blood pressure as risk factors for poor cognitive performance. Diabetes Care 1997; 20: 1388-1395.
25. Fontbonne A, Berr C, Ducimetiere P, Alperovitch A. Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 2001; 24: 366-370. (Pubitemid 32119140)
26. Gregg EW, Yaffe K, Cauley JA, et al. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 2000; 160: 174-180.
27. Korf ES, van Straaten EC, de Leeuw FE, et al. Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study. Diabet Med 2007; 24: 166-171. (Pubitemid 46174940)
28. Perlmuter LC, Hakami MK, Hodgson-Harrington C, et al. Decreased cognitive function in aging non-insulin-dependent diabetic patients. Am J Med 1984; 77: 1043-1048. (Pubitemid 15221767)
29. Jagusch W, Cramon DYV, Renner R, Hepp KD. Cognitive function and metabolic state in elderly diabetic patients. Diabetes Nutr Metab 1992; 5: 265-274. (Pubitemid 23058810)
30. Munshi M, Grande L, Hayes M, et al. Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care 2006; 29: 1794-1799. (Pubitemid 44156632)
31. Ryan CM, Freed MI, Rood JA, Cobitz AR, Waterhouse BR, Strachan MW. Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diabetes Care 2006; 29: 345-351.
32. Gradman TJ, Laws A, Thompson LW, Reaven GM. Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus. J Am Geriatr Soc 1993; 41: 1305-1312. (Pubitemid 23353940)
33. Meneilly GS, Cheung E, Tessier D, Yakura C, Tuokko H. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. J Gerontol 1993; 48:M117-M121. (Pubitemid 23199244)
34. Naor M, Steingruber HJ, Westhoff K, Schottenfeld-Naor Y, Gries AF. Cognitive function in elderly non-insulin-dependent diabetic patients before and after inpatient treatment for metabolic control. J Diabetes Complications 1997; 11: 40-46. (Pubitemid 27077768)
35. Abbatecola AM, Rizzo MR, Barbieri M, et al. Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics. Neurology 2006; 67: 235-240. (Pubitemid 44305405)
36. Areosa Sastre A, Grimley Evans V. Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementia. Cochrane Database Syst Rev 2002; 4: 1-20. CD003804.
37. Chatfield MD, Brayne CE, Matthews FE. A systematic literature review of attrition between waves in longitudinal studies in the elderly shows a consistent pattern of dropout between differing studies. J Clin Epidemiol 2005; 58: 13-19.
38. de Mutsert R, Snijder MB, van der Sman-de Beer, et al. Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol 2007; 18: 967-974.
39. de Vegt F, Dekker JM, Ruhe HG, et al. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 1999; 42: 926-931. (Pubitemid 29369599)
40. Rijkelijkhuizen JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD, Dekker JM. High risk of cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes: the Hoorn study. Diabetes Care 2007; 30: 332-336. (Pubitemid 46198339)
41. Dekker JM, Girman C, Rhodes T, et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 2005; 112: 666-673. (Pubitemid 41099045)